Cardiovascular Technologies
From first principles to First-in-human in cardiovascular innovation
Hydrix brings over a decade of experience in cardiovascular innovation, partnering on artificial hearts, VADs, catheter-based systems, and more.
Our team has delivered key contributions to Mechanical Circulatory Support systems and a broad range of cardiovascular platforms, applying deep expertise in safety-critical software, electronics, systems engineering, and human-centered design. We support clients through every stage, from proof of concept and preclinical testing to first-in-human trials and commercial launch
Mechanical Circulatory Support Systems
We support the development of artificial hearts, ventricular assist devices, and extracorporeal systems. Our expertise spans safety-critical software, electronics, and control systems, helping clients advance from benchtop prototypes to first-in-human trials and commercial launch.
Minimally Invasive and Catheter-Based Devices
We design interventional tools for cardiovascular access, closure, and sensing. This includes catheter-based systems with integrated monitoring and control, combining mechanical design, fluid dynamics, and embedded electronics for precision and safety.
Cardiac Monitoring and Connected Systems
We develop wearable, implantable, and connected devices for real-time monitoring of cardiac function. Our work includes ECG systems, pressure sensors, and remote data platforms designed to meet clinical accuracy, usability, and regulatory demands.
Over a decade of advancing
Mechanical Circulatory Support systems
Hydrix has contributed to some of the most ambitious MCS programs of the past decade, with several now advancing into First-in-Human trials and beyond.
LUDO: Powering the Next Generation of MCS innovation
LUDO is a real-time control and test platform developed by Hydrix to accelerate the development of LVADs and Total Artificial Hearts. Designed for flexibility and speed, it enables rapid iteration, validation of pump control strategies, and smooth progression toward preclinical and First in Human studies.
Already in use by global leaders including the Texas Heart Institute, LUDO is now being adopted as a foundational tool for a new wave of breakthrough MCS programs.
We turn bold cardiovascular ideas into life-sustaining realities
Pioneering Cardiac Pacemaker System
Ceryx Medical, a UK-based innovator in bioelectronics, is developing a cutting-edge cardiac pacemaker system designed to enhance heart function by mimicking the body’s natural rhythms. Leverage…
New Era in Artificial Heart Technology
Scandinavian RealHeart (SRH), a Swedish medtech company, is redefining the future of mechanical circulatory support with its groundbreaking Total Artificial Heart (TAH). Inspired by the human…
Redefining MCS Controllers
With Hydrix’s deep understanding of the MCS market, has pioneered, a plug-and-play platform transforming the design and development of artificial hearts and ventricular assist devices (VADs)…